Acute Leukemia
3 competing products in clinical development for Acute Leukemia.
Pipeline by Phase
Phase 11
Phase 1/21
Phase 21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Micafungin | Astellas Pharma | Phase 2 | Completed | 35 |
| ONO-7475 3mg once daily + ONO-7475 6mg once daily + ONO-7475 10mg once daily + ONO-7475 6mg + Venetoclax (70-400mg) | Ono Pharmaceutical | Phase 1/2 | Terminated | 24 |
| LY2523355 | Eli Lilly | Phase 1 | Terminated | 21 |